These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21768882)

  • 1. Octreotide management of intestinal lymphangiectasia in a teenage heart transplant patient.
    Altit G; Patel H; Morinville VD
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):824-7. PubMed ID: 21768882
    [No Abstract]   [Full Text] [Related]  

  • 2. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.
    Filik L; Oguz P; Koksal A; Koklu S; Sahin B
    Dig Liver Dis; 2004 Oct; 36(10):687-90. PubMed ID: 15506669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide in the treatment of intestinal lymphangiectasia.
    Ballinger AB; Farthing MJ
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):699-702. PubMed ID: 9744700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment?
    Sari S; Baris Z; Dalgic B
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the objectives of treatment for intestinal lymphangiectasia?
    Takahashi H; Imai K
    J Gastroenterol; 2001 Feb; 36(2):137-8. PubMed ID: 11227672
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary intestinal lymphangiectasia successfully treated with octreotide.
    Kuroiwa G; Takayama T; Sato Y; Takahashi Y; Fujita T; Nobuoka A; Kukitsu T; Kato J; Sakamaki S; Niitsu Y
    J Gastroenterol; 2001 Feb; 36(2):129-32. PubMed ID: 11227670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.
    Makhija S; von der Weid PY; Meddings J; Urbanski SJ; Beck PL
    Can J Gastroenterol; 2004 Nov; 18(11):681-5. PubMed ID: 15565209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to treat an extensive form of primary intestinal lymphangiectasia?
    Troskot R; Jurčić D; Bilić A; Gomerčić Palčić M; Težak S; Brajković I
    World J Gastroenterol; 2015 Jun; 21(23):7320-5. PubMed ID: 26109821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary intestinal lymphangiectasia: effectiveness of treatment with slow-release octreotide].
    Balboa A; Perelló A; Mearin F
    Med Clin (Barc); 2004 Sep; 123(8):319. PubMed ID: 15373983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role octreotide in prevention of complications after pancreatoduodenal resections].
    Shatverian GA; Ratnikova NP; Mikhaĭlov IuE; Bedzhanian AL; Sidorov AN; Fisenko EP; Skipenko OG
    Khirurgiia (Mosk); 2004; (2):56-60. PubMed ID: 14997883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastrointestinal fistulas. Treatment with a somatostatin analogue (SMS 201-995)].
    Gerardo Pérez D; Bernardo Acosta M
    G E N; 1994; 48(4):209-18. PubMed ID: 7557275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of enterocutaneous fistula with or without octreotide and parenteral nutrition].
    Hernández-Aranda JC; Gallo-Chico B; Flores-Ramírez LA; Avalos-Huante R; Magos-Vázquez FJ; Ramírez-Barba EJ
    Nutr Hosp; 1996; 11(4):226-9. PubMed ID: 8962902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loculated neonatal chylothorax treated with octreotide: complete recovery while on unrestricted full fat breast milk.
    Roehr CC; Jung A; Curcin OA; Proquitte H; Hammer H; Wauer RR
    Ann Thorac Surg; 2005 Nov; 80(5):1981-2; author reply 1982. PubMed ID: 16242514
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory primary intestinal lymphangiectasia effectively managed with subcutaneous octreotide.
    Halim A; Youd P; Thorpe J; Halim I
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33837021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postoperative refractory chylothorax which was improved by octreotide acetate].
    Gabe A; Seki M; Taira N; Katsura M; Ishida T; Kang Y; Kubota T; Yamashiro T; Uehara T; Sunagawa T; Ohkubo K
    Kyobu Geka; 2012 Mar; 65(3):230-3. PubMed ID: 22374601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of postoperative pancreatitis, in patients undergoing cholecystectomy for cholelithiasis].
    Vakhrushev IaM; Kropacheva NS
    Eksp Klin Gastroenterol; 2010; (8):42-5. PubMed ID: 21268325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Octreotide in digestive surgery].
    Cardona D; Clopés A
    Rev Esp Enferm Dig; 1998 Oct; 90(10):683-6. PubMed ID: 9824932
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide may prevent definitive intestinal obstruction.
    Mercadante S; Kargar J; Nicolosi G
    J Pain Symptom Manage; 1997 Jun; 13(6):352-5. PubMed ID: 9204656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.
    Al Sinani S; Rawahi YA; Abdoon H
    World J Gastroenterol; 2012 Nov; 18(43):6333-7. PubMed ID: 23180957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.